Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics

Journal of Proteome Research

Volumn 13, Issue 11, 2014, Pages 4919-4931

  Shin, Jihye ^a,b   Kim, Hye Jung ^a   Kim, Gamin ^a,c   Song, Meiying ^c   Woo, Se Joon ^d   Lee, Seung Taek ^b   Kim, Hoguen ^c   Lee, Cheolju ^a,e  

^a Korea Institute of Science and Technology   (South Korea)

^b Yonsei University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Seoul National University Bundang Hospital   (South Korea)

^e University of Science and Technology (UST)   (South Korea)

Author keywords

colorectal cancer; ICAT; melanotransferrin; mTRAQ; secretome; serological marker

Indexed keywords

ASPARTATE AMMONIA LIGASE; CARCINOEMBRYONIC ANTIGEN; IMPORTIN 5; MELANOTRANSFERRIN; NUCLEOSOME ASSEMBLY PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLY(RC) BINDING PROTEIN 2; PROCOLLAGEN LYSINE 2 OXOGLUTARATE 5 DIOXYGENASE; PROTEIN TYROSINE KINASE 7; RPE SPONDIN; SCLEROPROTEIN; SERPIN H1; TENASCIN; TRANSFERRIN; TUMOR MARKER; UNCLASSIFIED DRUG; MELANOTRANSFERRIN PROTEIN, HUMAN; MEMBRANE PROTEIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CELL MEMBRANE; CELL NUCLEUS; CELLULAR DISTRIBUTION; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL POLYP; CONTROLLED STUDY; CYTOPLASM; DATA MINING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SPACE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEROLOGY; UPREGULATION; WESTERN BLOTTING; BIOLOGY; BLOOD; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION; GENETICS; LIQUID CHROMATOGRAPHY; PHYSIOLOGY; PROCEDURES; TANDEM MASS SPECTROMETRY;

AREA UNDER CURVE; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CHROMATOGRAPHY, LIQUID; COLORECTAL NEOPLASMS; COMPUTATIONAL BIOLOGY; DATA MINING; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 84908892144     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500790f     Document Type: Article

References (67)

1. Siegel, R.; Ma, J.; Zou, Z.; Jemal, A. Cancer statistics, 2014 CA Cancer J. Clin 2014, 64 (1) 9-29
2. Jung, K. W.; Won, Y. J.; Kong, H. J.; Oh, C. M.; Seo, H. G.; Lee, J. S. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010 Cancer Res. Treat 2013, 45 (1) 1-14
3. Gatta, G.; Ciccolallo, L.; Capocaccia, R.; Coleman, M. P.; Hakulinen, T.; Möller, H.; Berrino, F. Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology Eur. J. Cancer 2003, 39 (15) 2214-2222
4. Inger, D. B. Colorectal cancer screening Primary Care 1999, 26 (1) 179-187
5. Collins, J. F.; Lieberman, D. A.; Durbin, T. E.; Weiss, D. G. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice Ann. Int. Med. 2005, 142 (2) 81-85
6. Winawer, S.; Fletcher, R.; Rex, D.; Bond, J.; Burt, R.; Ferrucci, J.; Ganiats, T.; Levin, T.; Woolf, S.; Johnson, D.; Kirk, L.; Litin, S.; Simmang, C. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence Gastroenterology 2003, 124 (2) 544-560
7. Gupta, S.; Sussman, D. A.; Doubeni, C. A.; Anderson, D. S.; Day, L.; Deshpande, A. R.; Elmunzer, B. J.; Laiyemo, A. O.; Mendez, J.; Somsouk, M.; Allison, J.; Bhuket, T.; Geng, Z.; Green, B. B.; Itzkowitz, S. H.; Martinez, M. E. Challenges and possible solutions to colorectal cancer screening for the underserved J. Natl. Cancer Inst. 2014, 106 (4) dju032
8. Gold, P.; Freedman, S. O. Demonstration of Tumor-Specific Antigens in Human Colonic Carcinomata by Immunological Tolerance and Absorption Techniques J. Exp. Med. 1965, 121, 439-462
9. Tjalsma, H. Identification of biomarkers for colorectal cancer through proteomics-based approaches Expert Rev. Proteomics 2010, 7 (6) 879-895
10. Polanski, M.; Anderson, N. L. A list of candidate cancer biomarkers for targeted proteomics Biomarker Insights 2007, 1, 1-48
11. Yamashita, K.; Watanabe, M. Clinical significance of tumor markers and an emerging perspective on colorectal cancer Cancer Sci. 2009, 100 (2) 195-199
12. Veenstra, T. D.; Conrads, T. P.; Hood, B. L.; Avellino, A. M.; Ellenbogen, R. G.; Morrison, R. S. Biomarkers: mining the biofluid proteome Mol. Cell. Proteomics 2005, 4 (4) 409-418
13. Schmidt, A.; Aebersold, R. High-accuracy proteome maps of human body fluids Genome Biol. 2006, 7 (11) 242
14. Hanash, S. M.; Pitteri, S. J.; Faca, V. M. Mining the plasma proteome for cancer biomarkers Nature 2008, 452 (7187) 571-579
15. Anderson, N. L.; Anderson, N. G. The human plasma proteome: history, character, and diagnostic prospects Mol. Cell. Proteomics 2002, 1 (11) 845-867
16. Tang, H. Y.; Ali-Khan, N.; Echan, L. A.; Levenkova, N.; Rux, J. J.; Speicher, D. W. A novel four-dimensional strategy combining protein and peptide separation methods enables detection of low-abundance proteins in human plasma and serum proteomes Proteomics 2005, 5 (13) 3329-3342
17. Rai, A. J.; Gelfand, C. A.; Haywood, B. C.; Warunek, D. J.; Yi, J.; Schuchard, M. D.; Mehigh, R. J.; Cockrill, S. L.; Scott, G. B.; Tammen, H.; Schulz-Knappe, P.; Speicher, D. W.; Vitzthum, F.; Haab, B. B.; Siest, G.; Chan, D. W. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples Proteomics 2005, 5 (13) 3262-3277
18. Chang, J. W.; Kang, U. B.; Kim, D. H.; Yi, J. K.; Lee, J. W.; Noh, D. Y.; Lee, C.; Yu, M. H. Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer Proteomics Clin. Appl. 2008, 2 (1) 23-32
19. Volmer, M. W.; Stuhler, K.; Zapatka, M.; Schoneck, A.; Klein-Scory, S.; Schmiegel, W.; Meyer, H. E.; Schwarte-Waldhoff, I. Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer Proteomics 2005, 5 (10) 2587-2601
20. Piersma, S. R.; Fiedler, U.; Span, S.; Lingnau, A.; Pham, T. V.; Hoffmann, S.; Kubbutat, M. H.; Jimenez, C. R. Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum J. Proteome Res. 2010, 9 (4) 1913-1922
21. Hathout, Y. Approaches to the study of the cell secretome Expert Rev. Proteomics 2007, 4 (2) 239-248
22. Pavlou, M. P.; Diamandis, E. P. The cancer cell secretome: a good source for discovering biomarkers? J. Proteomics 2010, 73 (10) 1896-1906
23. Gygi, S. P.; Rist, B.; Gerber, S. A.; Turecek, F.; Gelb, M. H.; Aebersold, R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags Nat. Biotechnol. 1999, 17 (10) 994-999
24. Kang, U. B.; Yeom, J.; Kim, H.; Lee, C. Quantitative analysis of mTRAQ-labeled proteome using full MS scans J. Proteome Res. 2010, 9 (7) 3750-3758
25. Kang, U. B.; Yeom, J.; Kim, H. J.; Kim, H.; Lee, C. Expression profiling of more than 3500 proteins of MSS-type colorectal cancer by stable isotope labeling and mass spectrometry J. Proteomics 2012, 75 (10) 3050-3062
26. Bjorling, E.; Lindskog, C.; Oksvold, P.; Linne, J.; Kampf, C.; Hober, S.; Uhlen, M.; Ponten, F. A web-based tool for in silico biomarker discovery based on tissue-specific protein profiles in normal and cancer tissues Mol. Cell. Proteomics 2008, 7 (5) 825-844
27. Bendtsen, J. D.; Nielsen, H.; von Heijne, G.; Brunak, S. Improved prediction of signal peptides: SignalP 3.0 J. Mol. Biol. 2004, 340 (4) 783-795
28. Bendtsen, J. D.; Jensen, L. J.; Blom, N.; Von Heijne, G.; Brunak, S. Feature-based prediction of non-classical and leaderless protein secretion Protein Eng., Des. Sel. 2004, 17 (4) 349-56
29. Möller, S.; Croning, M. D.; Apweiler, R. Evaluation of methods for the prediction of membrane spanning regions Bioinformatics 2001, 17 (7) 646-653
30. Nesvizhskii, A. I.; Keller, A.; Kolker, E.; Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry Anal. Chem. 2003, 75 (17) 4646-4658
31. Omenn, G. S.; States, D. J.; Adamski, M.; Blackwell, T. W.; Menon, R.; Hermjakob, H.; Apweiler, R.; Haab, B. B.; Simpson, R. J.; Eddes, J. S.; Kapp, E. A.; Moritz, R. L.; Chan, D. W.; Rai, A. J.; Admon, A.; Aebersold, R.; Eng, J.; Hancock, W. S.; Hefta, S. A.; Meyer, H.; Paik, Y. K.; Yoo, J. S.; Ping, P.; Pounds, J.; Adkins, J.; Qian, X.; Wang, R.; Wasinger, V.; Wu, C. Y.; Zhao, X.; Zeng, R.; Archakov, A.; Tsugita, A.; Beer, I.; Pandey, A.; Pisano, M.; Andrews, P.; Tammen, H.; Speicher, D. W.; Hanash, S. M. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database Proteomics 2005, 5 (13) 3226-3245
32. Youden, W. J. Index for rating diagnostic tests Cancer 1950, 3 (1) 32-35
33. Herszenyi, L.; Plebani, M.; Carraro, P.; De Paoli, M.; Roveroni, G.; Cardin, R.; Tulassay, Z.; Naccarato, R.; Farinati, F. The role of cysteine and serine proteases in colorectal carcinoma Cancer 1999, 86 (7) 1135-1142
34. Herszenyi, L.; Farinati, F.; Cardin, R.; Istvan, G.; Molnar, L. D.; Hritz, I.; De Paoli, M.; Plebani, M.; Tulassay, Z. Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer BMC Cancer 2008, 8, 194
35. Rolland, Y.; Demeule, M.; Beliveau, R. Melanotransferrin stimulates t-PA-dependent activation of plasminogen in endothelial cells leading to cell detachment Biochim. Biophys. Acta 2006, 1763 (4) 393-401
36. Schaaij-Visser, T. B.; de Wit, M.; Lam, S. W.; Jimenez, C. R. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context Biochim. Biophys. Acta 2013, 1834 (11) 2242-2258
37. Luo, Y.; Wang, L.; Wang, J. Developing proteomics-based biomarkers for colorectal neoplasms for clinical practice: opportunities and challenges Proteomics Clin. Appl. 2013, 7 (1-2) 30-41
38. Tanaka, T.; Tanaka, M.; Ishigamori, R. Biomarkers for colorectal cancer Int. J. Mol. Sci. 2010, 11 (9) 3209-3225
39. Diehl, H. C.; Stuhler, K.; Klein-Scory, S.; Volmer, M. W.; Schoneck, A.; Bieling, C.; Schmiegel, W.; Meyer, H. E.; Schwarte-Waldhoff, I. A catalogue of proteins released by colorectal cancer cells in vitro as an alternative source for biomarker discovery Proteomics Clin. Appl. 2007, 1 (1) 47-61
40. Kim, H. J.; Kang, H. J.; Lee, H.; Lee, S. T.; Yu, M. H.; Kim, H.; Lee, C. Identification of S100A8 and S100A9 as serological markers for colorectal cancer J. Proteome Res. 2009, 8 (3) 1368-1379
41. Jungblut, P. R.; Zimny-Arndt, U.; Zeindl-Eberhart, E.; Stulik, J.; Koupilova, K.; Pleissner, K. P.; Otto, A.; Muller, E. C.; Sokolowska-Kohler, W.; Grabher, G.; Stoffler, G. Proteomics in human disease: cancer, heart and infectious diseases Electrophoresis 1999, 20 (10) 2100-2110
42. Alfonso, P.; Nunez, A.; Madoz-Gurpide, J.; Lombardia, L.; Sanchez, L.; Casal, J. I. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis Proteomics 2005, 5 (10) 2602-2611
43. Nishizuka, S.; Chen, S. T.; Gwadry, F. G.; Alexander, J.; Major, S. M.; Scherf, U.; Reinhold, W. C.; Waltham, M.; Charboneau, L.; Young, L.; Bussey, K. J.; Kim, S.; Lababidi, S.; Lee, J. K.; Pittaluga, S.; Scudiero, D. A.; Sausville, E. A.; Munson, P. J.; Petricoin, E. F., 3rd; Liotta, L. A.; Hewitt, S. M.; Raffeld, M.; Weinstein, J. N. Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling Cancer Res. 2003, 63 (17) 5243-5250
44. Ma, Y.; Peng, J.; Liu, W.; Zhang, P.; Huang, L.; Gao, B.; Shen, T.; Zhou, Y.; Chen, H.; Chu, Z.; Zhang, M.; Qin, H. Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer Mol. Cell. Proteomics 2009, 8 (8) 1878-1890
45. Uzozie, A.; Nanni, P.; Staiano, T.; Grossmann, J.; Barkow-Oesterreicher, S.; Shay, J. W.; Tiwari, A.; Buffoli, F.; Laczko, E.; Marra, G. Sorbitol dehydrogenase overexpression and other aspects of dysregulated protein expression in human precancerous colorectal neoplasms: a quantitative proteomics study Mol. Cell. Proteomics 2014, 13 (5) 1198-1218
46. Besson, D.; Pavageau, A. H.; Valo, I.; Bourreau, A.; Belanger, A.; Eymerit-Morin, C.; Mouliere, A.; Chassevent, A.; Boisdron-Celle, M.; Morel, A.; Solassol, J.; Campone, M.; Gamelin, E.; Barre, B.; Coqueret, O.; Guette, C. A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker Mol. Cell. Proteomics 2011, 10 (12) M111 009712
47. Yin, H. R.; Zhang, L.; Xie, L. Q.; Huang, L. Y.; Xu, Y.; Cai, S. J.; Yang, P. Y.; Lu, H. J. Hyperplex-MRM: a hybrid multiple reaction monitoring method using mTRAQ/iTRAQ labeling for multiplex absolute quantification of human colorectal cancer biomarker J. Proteome Res. 2013, 12 (9) 3912-3919
48. Harsha, H. C.; Kandasamy, K.; Ranganathan, P.; Rani, S.; Ramabadran, S.; Gollapudi, S.; Balakrishnan, L.; Dwivedi, S. B.; Telikicherla, D.; Selvan, L. D.; Goel, R.; Mathivanan, S.; Marimuthu, A.; Kashyap, M.; Vizza, R. F.; Mayer, R. J.; Decaprio, J. A.; Srivastava, S.; Hanash, S. M.; Hruban, R. H.; Pandey, A. A compendium of potential biomarkers of pancreatic cancer PLoS Med. 2009, 6 (4) e1000046
49. Bernhard, O. K.; Greening, D. W.; Barnes, T. W.; Ji, H.; Simpson, R. J. Detection of cadherin-17 in human colon cancer LIM1215 cell secretome and tumour xenograft-derived interstitial fluid and plasma Biochim. Biophys. Acta 2013, 1834 (11) 2372-2379
50. Mathivanan, S.; Lim, J. W.; Tauro, B. J.; Ji, H.; Moritz, R. L.; Simpson, R. J. Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature Mol. Cell. Proteomics 2010, 9 (2) 197-208
51. Xue, H.; Lu, B.; Lai, M. The cancer secretome: a reservoir of biomarkers J. Transl. Med. 2008, 6, 52
52. Wu, C. C.; Chen, H. C.; Chen, S. J.; Liu, H. P.; Hsieh, Y. Y.; Yu, C. J.; Tang, R.; Hsieh, L. L.; Yu, J. S.; Chang, Y. S. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes Proteomics 2008, 8 (2) 316-332
53. Rangiah, K.; Tippornwong, M.; Sangar, V.; Austin, D.; Tetreault, M. P.; Rustgi, A. K.; Blair, I. A.; Yu, K. H. Differential secreted proteome approach in murine model for candidate biomarker discovery in colon cancer J. Proteome Res. 2009, 8 (11) 5153-5164
54. Yao, L.; Lao, W.; Zhang, Y.; Tang, X.; Hu, X.; He, C.; Xu, L. X. Identification of EFEMP2 as a Serum Biomarker for the Early Detection of Colorectal Cancer with Lectin Affinity Capture Assisted Secretome Analysis of Cultured Fresh Tissues J. Proteome Res. 2012, 11 (6) 3281-3294
55. Makridakis, M.; Vlahou, A. Secretome proteomics for discovery of cancer biomarkers J. Proteomics 2010, 73 (12) 2291-2305
56. Ji, H.; Greening, D. W.; Kapp, E. A.; Moritz, R. L.; Simpson, R. J. Secretome-based proteomics reveals sulindac-modulated proteins released from colon cancer cells Proteomics Clin. Appl. 2009, 3 (4) 433-451
57. Mathivanan, S.; Ji, H.; Tauro, B. J.; Chen, Y. S.; Simpson, R. J. Identifying mutated proteins secreted by colon cancer cell lines using mass spectrometry J. Proteomics 2012, 76 (Spec No.) 141-149
58. Karagiannis, G. S.; Pavlou, M. P.; Saraon, P.; Musrap, N.; Xie, A.; Batruch, I.; Prassas, I.; Dimitromanolakis, A.; Petraki, C.; Diamandis, E. P. In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers J. Proteomics 2014, 103, 121-136
59. de Wit, M.; Kant, H.; Piersma, S. R.; Pham, T. V.; Mongera, S.; van Berkel, M. P.; Boven, E.; Ponten, F.; Meijer, G. A.; Jimenez, C. R.; Fijneman, R. J. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling J. Proteomics 2014, 99, 26-39
60. Chen, Y. J.; Ching, W. C.; Chen, J. S.; Lee, T. Y.; Lu, C. T.; Chou, H. C.; Lin, P. Y.; Khoo, K. H.; Chen, J. H.; Chen, Y. J. Decoding the S-Nitrosoproteomic Atlas in Individualized Human Colorectal Cancer Tissues Using a Label-Free Quantitation Strategy J. Proteome Res. 2014, 10.1021/pr5002675
61. Wu, C. C.; Hsu, C. W.; Chen, C. D.; Yu, C. J.; Chang, K. P.; Tai, D. I.; Liu, H. P.; Su, W. H.; Chang, Y. S.; Yu, J. S. Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas Mol. Cell. Proteomics 2010, 9 (6) 1100-1117
62. Ralhan, R.; Masui, O.; Desouza, L. V.; Matta, A.; Macha, M.; Siu, K. W. Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers Proteomics 2011, 11 (12) 2363-2376
63. Rothenberger, S.; Food, M. R.; Gabathuler, R.; Kennard, M. L.; Yamada, T.; Yasuhara, O.; McGeer, P. L.; Jefferies, W. A. Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium Brain Res. 1996, 712 (1) 117-121
64. Richardson, D. R. The role of the membrane-bound tumour antigen, melanotransferrin (p97), in iron uptake by the human malignant melanoma cell Eur. J. Biochem. 2000, 267 (5) 1290-1298
65. Food, M. R.; Sekyere, E. O.; Richardson, D. R. The soluble form of the membrane-bound transferrin homologue, melanotransferrin, inefficiently donates iron to cells via nonspecific internalization and degradation of the protein Eur. J. Biochem. 2002, 269 (18) 4435-4445
66. Suryo Rahmanto, Y.; Bal, S.; Loh, K. H.; Yu, Y.; Richardson, D. R. Melanotransferrin: search for a function Biochim. Biophys. Acta 2012, 1820 (3) 237-243
67. Demeule, M.; Bertrand, Y.; Michaud-Levesque, J.; Jodoin, J.; Rolland, Y.; Gabathuler, R.; Beliveau, R. Regulation of plasminogen activation: a role for melanotransferrin (p97) in cell migration Blood 2003, 102 (5) 1723-1731